Skip to main content

Table 2 Effect of FCM on haemoglobin concentration, iron indices and mineral metabolism parameters

From: Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study

 

Baseline

Week 3

Week 12

p-value

Haemoglobin, g/dL

10(0.7)

10.8(0.8)

11.4(1.3)

<0.0001

TSAT, %

14.6(6.4)

28.9(10)

25.6(12.7)

<0.0001

Ferritin, ng/mL

67.8(61.7)

502.5(263.3)

230(144.6)

<0.0001

Calcium, mg/dl

9.3(0.4)

9.3(0.5)

9.3(0.5)

ns

Phosphate, mg/dL

4.2(0.8)

3.6(1.1)

3.8(0.6)

<0.0001

PTH, pg/ml

138.1(2.5-600)

124(2.5-736)

106.5(2.5-613)

ns

1,25(OH)2 D, pg/mL

9.7(4.4)

10(3.7)

10.4(5.4)

ns

FGF23, RU/mL

442(44.9-4079.2)

340(68.5-2603.3)

191.6(51.3-2465.9)

<0.0001

  1. TAST: transferrin saturation.